Lonza Group, CH0013841017

Goldman Sachs keeps Buy rating for Lonza Group stock at CHF 680.00

Published on 10/13/2026 at 13:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Half-Year 2026 sales reached CHF 3.4 billion. Lonza Group stock costs EUR 613.70 on October 13, 2026, down 0.52 percent on SIX.

  • Goldman Sachs maintained its Buy rating and a CHF 680.00 target for Lonza Group on October 2, 2026.
  • Half-Year 2026 sales reached CHF 3.4 billion, according to Lonza's October 12 release.
  • Lonza Group stock costs EUR 613.70 at Lang & Schwarz on October 13, 2026 at 1:09 p.m. CEST, down 0.52 percent on SIX.
  • A 23-analyst average target of CHF 688.17 and a 0.90 percent dividend yield frame valuation as of October 6, 2026.
Flatlay von Laborutensilien auf weißem Tisch: Pipetten, Petrischalen und blaue Schutzhandschuhe
Lonza CH0013841017 Flatlay Labor Pipetten Petrischalen blaue Schutzhandschuhe auf weissem Tisch anonym, Illustration mit AI erstellt.

Goldman Sachs maintained its Buy rating on Lonza Group stock and a CHF 680.00 price target in a report dated October 2, 2026, as The Globe and Mail reported. The target is 19.09 percent above the CHF 571.00 SIX price cited for the same session. Lonza Group stock was at EUR 613.70 at Lang & Schwarz on October 13, 2026 at 1:09 p.m. CEST, down 0.52 percent on the day on SIX.

Half-Year sales reach CHF 3.4 billion

Lonza reported sales of CHF 3.4 billion and CORE EBITDA of CHF 1.2 billion for Half-Year 2026 in its October 12, 2026 release. The figures were published by EQS News in the release on Lonza's dual-payload antibody-drug conjugate agreement with Qurient.

Stock stays below its 52-week high

The SIX share price was CHF 571.00 at 12:58 p.m. CEST on October 13, 2026, against a 52-week range of CHF 454.60 to CHF 597.80. That places the home-market price 4.48 percent below the yearly high, while Lonza's market capitalization stood at CHF 39.9 billion on the same date.

Valuation and October events

Lonza's price-to-earnings ratio was 38.20 and its dividend yield was 0.90 percent as of October 6, 2026. TickerLandia also listed an average CHF 688.17 target from 23 analysts. A Capital Markets Day was scheduled for October 13 and October 14, 2026, with a qualitative third-quarter business update announced for October 14, as Stock-World reported on October 12.

Comparison with peers

Lonza Group (SIX, CHF): minus 0.52 percent, market capitalization CHF 39.9 billion on October 13, 2026.

Thermo Fisher Scientific (NYSE, USD): plus 0.64 percent, price-to-earnings ratio 35.62, market capitalization USD 244.9 billion on October 12, 2026.

argenx (Euronext Brussels, EUR): plus 0.55 percent, price-to-earnings ratio 31.62, market capitalization EUR 45.8 billion on October 13, 2026.

Price and trading details

The Lang & Schwarz quote showed a bid of EUR 613.60 and an ask of EUR 613.80 at 1:09 p.m. CEST on October 13, 2026. The SIX close used for the daily comparison was CHF 574.00 on October 12, 2026, while the euro quotation reflects the German trading perspective.

The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.

Lonza Group stock facts

  • Company: Lonza Group AG
  • ISIN: CH0013841017
  • Ticker: LONN
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz (as of October 13, 2026, 1:09 p.m. CEST): EUR 613.70
  • Change on SIX: minus 0.52 percent
  • SIX close (October 12, 2026): CHF 574.00
  • Market capitalization: CHF 39.9 billion (as of October 13, 2026)
  • 52-week range: CHF 454.60-597.80 (as of October 13, 2026)
  • Sector / Industry: Healthcare / Biotechnology

More news and analyses on Lonza Group stock

Market context: Market report SMI.

Disclaimer...

en | CH0013841017 | LONZA GROUP | boerse | 70313744 | bgmi